Abbott FreeStyle Libre Monitoring Device May Give Inaccurate Blood Glucose Reading
You may be eligible for compensationMedical device maker Abbott Diabetes Care, Inc., has issued a voluntary recall for some of its FreeStyle Libre 3 blood glucose devices. The company has acknowledged that the glucose sensor devices may give false results of high or low blood glucose levels, prompting higher or lower than needed doses of insulin which may cause serious injury.
Abbott continuous glucose monitor (CGM) devices which have been affected by the recall include:
- Abbott FreeStyle Libre 3 Sensor
- Abbott FreeStyle Libre 3 Sensor Plus
Seven deaths and 736 serious injuries associated with the devices have been reported.
For a full list of impacted model numbers, see here: https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-glucose-monitor-sensor-issue-abbott-diabetes-care